10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
7 Analysts Have This to Say About Baxter Intl
Baxter Intl (NYSE:BAX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Software Update Leads To False Alarms In Baxter’s Spectrum Infusion Pumps, Urgent Correction Underway
Baxter International Inc (NYSE: BAX) has
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Keybanc cut the price target for Baxter International Inc. (NYSE: BAX) from $53 to $51. Keybanc analyst Matthew Mishan maintained an Overweight rating. Baxter International shares rose 1.2% to $47.58 in pre-market trading.
What 4 Analyst Ratings Have To Say About Baxter Intl
Over the past 3 months, 4 analysts have published their opinion on Baxter Intl (NYSE:BAX) stock. These analysts…
Baxter Posts Mixed Q2 Earnings, Stock Falls On Lagging FY23 Outlook
Baxter International Inc (NYSE: BAX) posted Q2 revenue of $3.71 billion, which missed the consensus of $3.79 billion, up 3% Y/Y on a reported basis and up
Earnings Scheduled For July 27, 2023
Companies Reporting Before The Bell
• SES AI (NYSE:SES) is projected to report quarterly earnings at $0.11 per share on revenue of $337.60 million.
Baxter’s Upcoming Q2 Earnings: Analyst Says Consistent Performance, Catalysts Can Accelerate Growth & Margins
As Baxter International Inc (NYSE: BAX) prepares to release its second-quarter 2023 financial results on July 27, Stifel analyst writes it is an opportune time for investors to consider owning BAX shares.